The Lancet, 398(10295), 143-155.
Reed J, Bain S, Kanamarlapudi V (2020) Recent advances in understanding the role of glucagon-like peptide
Abnormal levels can indicate issues like enzyme dysfunction or nutrient deficiencies
Results Cholelithiasis significantly associates GLP1-RAs (p = 0.033)
According to PubMed, recent comprehensive reviews document effects on cardiovascular protection (reduced major adverse cardiovascular events), neuroprotection (reduced neuroinflammation, potential effects on Alzheimer's pathology), renal protection (reduced albuminuria and renal decline), hepatic improvement (reduced steatosis and fibrosis markers), adipose tissue remodeling (enhanced mitochondrial biogenesis, beige adipocyte programming, reduced visceral fat inflammation), modulation of gut microbiota composition, and even preliminary signals in obstructive sleep apnoea, substance use disorders, and tumour biology (Lu et al., 2024, DOI
de la Garza and I